News

Context Therapeutics Announces Key Upcoming Investor Events

Context Therapeutics Announces Key Upcoming Investor Events

Context Therapeutics' Participation in Notable Investor Conferences

Context Therapeutics Inc. (NASDAQ: CNTX), a forward-thinking biopharmaceutical company focused on T cell engaging bispecific antibodies for solid tumors, is excited to share its upcoming involvement in several significant investor conferences. These gatherings present a wonderful opportunity for Context to connect with investors and industry experts while showcasing its innovative advancements in cancer treatments.

Details of the Upcoming Conferences

Context Therapeutics will take part in two prominent investor conferences where the company's leadership team will engage with participants. Below are the details of the conferences:

  • **Guggenheim 2nd Annual Healthcare Innovation Conference**
    Dates: November 10-12
    Fireside Chat: November 10 at 3:00 PM ET
    1x1 Meetings: November 10
  • **Stifel 2025 Healthcare Conference**
    Dates: November 11-13
    Presentation: November 12 at 10:00 AM ET
    1x1 Meetings: November 12

These events are pivotal for Context, as they allow for meaningful dialogue with potential investors and partners about the company's innovative product pipeline.

Webcast Information

A live webcast of the presentation from these conferences will be accessible through the News and Events section on Context Therapeutics' official website. Following the live sessions, replays will also be available for 90 days, ensuring that interested parties can catch up on the content at their convenience.

About Context Therapeutics Inc.

Context Therapeutics stands out in the biopharmaceutical field with its unique focus on T cell engaging bispecific therapeutics, essential for the treatment of various solid tumors. Notable products in their portfolio include CTIM-76 (a Claudin 6 x CD3 TCE), CT-95 (a Mesothelin x CD3 TCE), and CT-202 (a Nectin-4 x CD3 TCE). The company's ongoing commitment to research and development positions it as a key player in oncology treatment advancements.

Contact and Additional Information

For those interested in learning more or arranging a meeting with Context's management during these conferences, please do not hesitate to reach out. Contact Jennifer Minai-Azary, Chief Financial Officer, for further inquiries via email at IR@contexttherapeutics.com.

Frequently Asked Questions

1. What is the focus of Context Therapeutics?

Context Therapeutics specializes in developing T cell engaging bispecific antibodies aimed at treating solid tumors effectively.

2. When will Context present at the upcoming conferences?

Context will present at the Guggenheim Conference on November 10 and at the Stifel Conference on November 12.

3. How can I access the company’s presentations?

The presentations will be available via a live webcast on Context Therapeutics' official website, with replays accessible afterward.

4. Who can provide more information about Context Therapeutics?

For more information, you can contact Jennifer Minai-Azary, CFO of Context Therapeutics, at their investor relations email.

5. What innovative products does Context Therapeutics develop?

Context is developing a variety of bispecific therapeutic products including CTIM-76, CT-95, and CT-202 targeting various solid tumors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Derek Pesta Shines: Forbes Top Wealth Advisors 2026

Updated Category News Views 0

An Unwavering Dedication to Clients Every once in a while, the industry tips its hat to someone who truly knows what they're doing. Derek Pesta, head honcho at Pesta & Pesta Wealth Management, has landed on the 2026 Forbes Top Next-Gen Wealth Advisors Best-in-State list. It’s not just a pat on the back; it's a solid nod to the way he runs his game. You know it’s big...

Continue Reading
J.P. Morgan, Thunes Partner for Global Payment Integration

Updated Category News Views 1

You don't need a crystal ball to see J.P. Morgan's playing the long game by teaming up with Thunes. In this world, where cash is digital and the reach is global, it's all about speed and scale—brushing elbows with the right partners makes all the difference. Sometimes it's about knowing when to hitch your wagon to a reliable workhorse, especially when global commerce is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
RiskScout Rides High on Funding, Tackles Financial Crime

Updated Category News Views 2

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

Continue Reading
New Leadership at Newmark: Tech Focus Amplified

Updated Category News Views 0

A Strategic Leap in Tech Leadership Newmark Group, Inc. (NASDAQ: NMRK) has handed the digital reins to Mike Whitaker, bringing him on board as Group Chief Information Officer. If you're in the loop with commercial real estate, this shakeup shouldn't come as a surprise. Newmark's been pretty gung-ho about tightening their tech playbook, and Whitaker's appointment is just...

Continue Reading
Celina Graves Joins Expanding GoLive Streamers Platform

Updated Category News Views 1

Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....

Continue Reading
Schneider Electric Pushes Water Management Tech at WEFTEC

Updated Category News Views 0

Looks like Schneider Electric is diving headfirst into the choppy waters of utility management with its latest tech showcase at WEFTEC 2026. And trust me, the timing couldn't be more spot-on. With North America's water and wastewater systems groaning under the weight of aging infrastructure and cybersecurity threats, it’s about time someone brought something fresh to...

Continue Reading
Class Action Lawsuit Hits Desert Resort Management

Updated Category News Views 2

Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...

Continue Reading
Primrose Schools App: A Bold Step for Digital Literacy

Updated Category News Views 0

Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...

Continue Reading
PVOLVE Expands Reach with New Franchises in 2026

Updated Category News Views 0

The PVOLVE Fitness Craze Picks Up Momentum Seriously, if you hadn’t heard of PVOLVE before, now might be the time to get your ears in tune—and maybe consider hitting up one of their studios. They’ve been on an expansion tear, with franchise deals popping up like daisies in Washington and Wisconsin. It's the two new spots in Tacoma and Brookfield that are grabbing...

Continue Reading

Top 5 Most Recently Viewed Articles

Intellia Therapeutics Enhances Workforce with Inducement Grants

Updated Category News Views 214

Intellia Therapeutics Boosts Employee Incentives with Recent Grants CAMBRIDGE, Mass. — Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering force in the gene editing arena, has taken a significant step forward to attract top talent. The company recently announced that, at the start of January 2025, it awarded key inducement grants as part of its strategic plan to...

Continue Reading
Discover giveBeauty: A New Era in Wellness Gifting

Updated Category News Views 124

Introducing giveBeauty: Your Go-To Wellness Gift Card Excitement is building as giveBeauty unveils its innovative gift card that embodies the essence of beauty, health, and wellness. This unique card is set to debut at the Los Angeles Ultimate Women's Expo, taking place at the LA Convention Center. With the holiday season just around the corner, giveBeauty is poised to be...

Continue Reading
Global Atomic Unveils Impressive Q3 2025 Financial Performance

Updated Category News Views 200

Global Atomic Q3 2025 Results Overview Global Atomic Corporation, known for its unique combination of uranium mine development and cash-flowing zinc concentrate production, has recently shared its Q3 2025 operating and financial results. The company, listed on both the TSX and OTCQX with tickers GLO and GLATF, is on an impressive trajectory, showcasing its commitment to...

Continue Reading
Amundi SA Lowers Stake in Ageas Below 3% Threshold

Updated Category News Views 54

Amundi SA Reduces Its Stake in Ageas In a recent transparency notification, Amundi SA has informed Ageas that as of August 28, its ownership in Ageas has fallen below the important threshold of 3%, now at 2.89%. This change marks a significant shift in the ownership landscape of the well-known insurance firm. What Shareholding Thresholds Mean The reduction in Amundi's...

Continue Reading
Local Expertise: The Keystone of Real Estate Success

Updated Category News Views 15

Understanding the Local Pulse Ever thought buying or selling a home was a straight shot based on numbers? Think twice. When it comes to real estate, seasoned pros like Jan Finley of Santa Ynez argue that it’s deeper than digits and listings. It's about digging into the very soul of a place, understanding what makes it tick beyond what stats can tell. Sure, hello...

Continue Reading